Today, they are reshaping the management of obesity, reducing cardiovascular risk, improving metabolic health, and expanding into promising areas such as liver disease, kidney disease, and neurodegenerative disorders
Lip balms are quite popular during the winter season when the air is drier and lips may lose moisture at a much faster pace
In diabetes care, GLP-1 receptor agonists are often evaluated within a framework that prioritizes prevention of complications such as cardiovascular disease, nephropathy, and retinopathy
In December 2024, a phase IIa dose-ranging trial (NCT06717425 ) to investigate this drug began, and is due to end in December 2025 5
MariTide Name: Maridebart cafraglutide (MariTide, formerly AMG 133) Manufacturer: Amgen Current stage: US phase III trial currently underway (MARITIME, NCT06858839) Takeaway: The dual agonist/antagonist action of MariTide could promise higher weight loss with fewer side effects, with dosing at less frequent intervals but more studies are needed
If you have specific concerns about your dietary choices whilst taking Mounjaro, discussing these with your GP or diabetes specialist nurse will provide personalised guidance based on your individual health status, treatment goals, and any concurrent medical conditions